These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 18297286)
1. Inhibition of mitochondrial protein translation sensitizes melanoma cells to arsenic trioxide cytotoxicity via a reactive oxygen species dependent mechanism. Bowling BD; Doudican N; Manga P; Orlow SJ Cancer Chemother Pharmacol; 2008 Dec; 63(1):37-43. PubMed ID: 18297286 [TBL] [Abstract][Full Text] [Related]
2. Enhancement of arsenic trioxide cytotoxicity by dietary isothiocyanates in human leukemic cells via a reactive oxygen species-dependent mechanism. Doudican NA; Bowling B; Orlow SJ Leuk Res; 2010 Feb; 34(2):229-34. PubMed ID: 19540589 [TBL] [Abstract][Full Text] [Related]
3. ROS-mediated endoplasmic reticulum stress and mitochondrial dysfunction underlie apoptosis induced by resveratrol and arsenic trioxide in A549 cells. Gu S; Chen C; Jiang X; Zhang Z Chem Biol Interact; 2016 Feb; 245():100-9. PubMed ID: 26772155 [TBL] [Abstract][Full Text] [Related]
4. Sulforaphane synergistically enhances the cytotoxicity of arsenic trioxide in multiple myeloma cells via stress-mediated pathways. Doudican NA; Wen SY; Mazumder A; Orlow SJ Oncol Rep; 2012 Nov; 28(5):1851-8. PubMed ID: 22922937 [TBL] [Abstract][Full Text] [Related]
5. Epoxyeicosatrienoic acids attenuate reactive oxygen species level, mitochondrial dysfunction, caspase activation, and apoptosis in carcinoma cells treated with arsenic trioxide. Liu L; Chen C; Gong W; Li Y; Edin ML; Zeldin DC; Wang DW J Pharmacol Exp Ther; 2011 Nov; 339(2):451-63. PubMed ID: 21846841 [TBL] [Abstract][Full Text] [Related]
6. Genistein selectively potentiates arsenic trioxide-induced apoptosis in human leukemia cells via reactive oxygen species generation and activation of reactive oxygen species-inducible protein kinases (p38-MAPK, AMPK). Sánchez Y; Amrán D; Fernández C; de Blas E; Aller P Int J Cancer; 2008 Sep; 123(5):1205-14. PubMed ID: 18546268 [TBL] [Abstract][Full Text] [Related]
7. Arsenic trioxide-induced cytotoxicity in small cell lung cancer via altered redox homeostasis and mitochondrial integrity. Zheng CY; Lam SK; Li YY; Ho JC Int J Oncol; 2015 Mar; 46(3):1067-78. PubMed ID: 25572414 [TBL] [Abstract][Full Text] [Related]
8. MER1, a novel organic arsenic derivative, has potent PML-RARalpha-independent cytotoxic activity against leukemia cells. Golemovic M; Quintás-Cardama A; Manshouri T; Orsolic N; Duzkale H; Johansen M; Freireich EJ; Kantarjian H; Zingaro RA; Verstovsek S Invest New Drugs; 2010 Aug; 28(4):402-12. PubMed ID: 19468689 [TBL] [Abstract][Full Text] [Related]
9. Ethacrynic acid and a derivative enhance apoptosis in arsenic trioxide-treated myeloid leukemia and lymphoma cells: the role of glutathione S-transferase p1-1. Wang R; Liu C; Xia L; Zhao G; Gabrilove J; Waxman S; Jing Y Clin Cancer Res; 2012 Dec; 18(24):6690-701. PubMed ID: 23082001 [TBL] [Abstract][Full Text] [Related]
13. Increased apoptotic efficacy of lonidamine plus arsenic trioxide combination in human leukemia cells. Reactive oxygen species generation and defensive protein kinase (MEK/ERK, Akt/mTOR) modulation. Calviño E; Estañ MC; Simón GP; Sancho P; Boyano-Adánez Mdel C; de Blas E; Bréard J; Aller P Biochem Pharmacol; 2011 Dec; 82(11):1619-29. PubMed ID: 21889928 [TBL] [Abstract][Full Text] [Related]
14. Arsenic trioxide and ascorbic acid demonstrate promising activity against primary human CLL cells in vitro. Biswas S; Zhao X; Mone AP; Mo X; Vargo M; Jarjoura D; Byrd JC; Muthusamy N Leuk Res; 2010 Jul; 34(7):925-31. PubMed ID: 20171736 [TBL] [Abstract][Full Text] [Related]
15. Synergistic induction of apoptosis by sulindac and arsenic trioxide in human lung cancer A549 cells via reactive oxygen species-dependent down-regulation of survivin. Jin HO; Yoon SI; Seo SK; Lee HC; Woo SH; Yoo DH; Lee SJ; Choe TB; An S; Kwon TJ; Kim JI; Park MJ; Hong SI; Park IC; Rhee CH Biochem Pharmacol; 2006 Nov; 72(10):1228-36. PubMed ID: 16950207 [TBL] [Abstract][Full Text] [Related]
16. Galectin-3 inhibition sensitizes human renal cell carcinoma cells to arsenic trioxide treatment. Xu Y; Gu X; Gong M; Guo G; Han K; An R Cancer Biol Ther; 2013 Oct; 14(10):897-906. PubMed ID: 23917726 [TBL] [Abstract][Full Text] [Related]
17. Combination treatment with arsenic trioxide and phytosphingosine enhances apoptotic cell death in arsenic trioxide-resistant cancer cells. Park MT; Kang YH; Park IC; Kim CH; Lee YS; Chung HY; Lee SJ Mol Cancer Ther; 2007 Jan; 6(1):82-92. PubMed ID: 17237268 [TBL] [Abstract][Full Text] [Related]
18. Induction of apoptosis in arsenic trioxide-treated lung cancer A549 cells by buthionine sulfoximine. Han YH; Kim SZ; Kim SH; Park WH Mol Cells; 2008 Aug; 26(2):158-64. PubMed ID: 18596414 [TBL] [Abstract][Full Text] [Related]
19. Additive antitumor effect of arsenic trioxide with exposure to ionizing radiation to human acute promyelocytic leukemia HL‑60 cells. Morino Y; Sugiyama H; Yamane K; Kikuchi M; Yamanaka T; Honda K; Monzen S Oncol Rep; 2024 Aug; 52(2):. PubMed ID: 38963046 [TBL] [Abstract][Full Text] [Related]
20. Dihydroartemisinin Sensitizes Human Lung Adenocarcinoma A549 Cells to Arsenic Trioxide via Apoptosis. Chen H; Gu S; Dai H; Li X; Zhang Z Biol Trace Elem Res; 2017 Oct; 179(2):203-212. PubMed ID: 28261759 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]